首页> 外文期刊>Regulatory peptides. >Chronic infusion of angiotensin-(1-7) reduces heart angiotensin II levels in rats.
【24h】

Chronic infusion of angiotensin-(1-7) reduces heart angiotensin II levels in rats.

机译:长期输注血管紧张素-(1-7)会降低大鼠的心脏血管紧张素II水平。

获取原文
获取原文并翻译 | 示例
           

摘要

We tested the hypothesis that the actions of Angiotensin (Ang)-(1-7) in the heart could involve changes in tissue levels of Ang II. This possibility was addressed by determining the effect of chronic infusion of Ang-(1-7) on plasma and tissue angiotensins. Ang-(1-7) was infused subcutaneously (osmotic minipumps) in Wistar rats. Angiotensins were determined by radioimmunoassay (RIA) in plasma, heart, and kidney. Tissue and plasma angiotensin-converting enzyme (ACE) activity and plasma renin activity (PRA) were also measured. Cardiac and renal ACE2 mRNA levels and cardiac angiotensinogen mRNA levels were assessed by semi-quantitative polymerase chain reaction (PCR). AT(1) receptor number was evaluated by autoradiograph. Chronic infusion of Ang-(1-7) (2 mug/h, 6 days) produced a marked decrease of Ang II levels in the heart. A less pronounced but significant decrease of Ang-(1-7) was also observed. No significant changes were observed for Ang I. Ang II was not altered in the kidney. In this tissue, a significant increase of Ang-(1-7) and Ang I concentration was observed. A significant increase of plasma Ang-(1-7) and Ang II was also observed. Ang-(1-7) infusion did not change ACE activity or PRA. A selective slight significant increase in ACE2 expression in the heart was observed. Heart angiotensinogen mRNA as well as the number of Ang II binding sites did not change. These results suggest that AT(1) receptors-independent changes in heart Ang II concentration might contribute for the beneficial effects of Ang-(1-7) in the heart. Moreover, these results reinforce the hypothesis that this angiotensin plays an important site-specific role within the renin-angiotensin system.
机译:我们检验了血管紧张素(Ang)-(1-7)在心脏中的作用可能涉及Ang II组织水平变化的假设。通过确定长期输注Ang-(1-7)对血浆和组织血管紧张素的作用来解决这种可能性。在Wistar大鼠中皮下注射Ang-(1-7)(渗透性微型泵)。血管紧张素通过血浆,心脏和肾脏中的放射免疫测定法(RIA)确定。还测量了组织和血浆血管紧张素转换酶(ACE)活性以及血浆肾素活性(PRA)。通过半定量聚合酶链反应(PCR)评估心脏和肾脏ACE2 mRNA水平以及心脏血管紧张素原mRNA水平。通过放射线照相术评估AT(1)受体数目。长期输注Ang-(1-7)(2杯/小时,6天)使心脏中的Ang II水平显着下降。还观察到Ang-(1-7)的降低不太明显但显着。没有观察到Ang I的显着变化。AngII在肾脏中没有改变。在该组织中,观察到Ang-(1-7)和Ang I浓度显着增加。还观察到血浆Ang-(1-7)和Ang II的显着增加。 Ang-(1-7)输注不会改变ACE活性或PRA。观察到心脏中ACE2表达的选择性轻微显着增加。心脏血管紧张素原mRNA和Ang II结合位点的数量没有变化。这些结果表明,心脏Ang II浓度中AT(1)受体无关的变化可能有助于Ang-(1-7)在心脏中的有益作用。而且,这些结果进一步证实了这种血管紧张素在肾素-血管紧张素系统中起着重要的位点特异性作用的假设。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号